WAT
52
-2
UNH
29
-7
QRVO
53
-2
APD
34
-18
FLR
42
-3
DHI
33
-6
APH
58
2
NWS
44
-2
DVA
47
-2
O
50
-7
REGN
50
-3
DUK
50
-2
TRIP
57
-3
SBUX
36
-4
SLB
46
-2
MMM
57
-4
VIX
43
8
UA
26
-4
AIG
53
-3
INTU
58
-7
WAT
52
-2
UNH
29
-7
QRVO
53
-2
APD
34
-18
FLR
42
-3
DHI
33
-6
APH
58
2
NWS
44
-2
DVA
47
-2
O
50
-7
REGN
50
-3
DUK
50
-2
TRIP
57
-3
SBUX
36
-4
SLB
46
-2
MMM
57
-4
VIX
43
8
UA
26
-4
AIG
53
-3
INTU
58
-7
Financhill
Back

JPMorgan US Tech Leaders ETF Vs. Structure Therapeutics, Inc. Industry Stock Comparison

Buy
58

JTEK
JPMorgan US Tech Leaders ETF

Last Price:
$92.63
Seasonality Move:
8.72%
Buy
67

GPCR
Structure Therapeutics, Inc.

Last Price:
$69.99
Seasonality Move:
-31.39%
Buy
58
JPMorgan US Tech Leaders ETF (JTEK) is a Buy

Is JPMorgan US Tech Leaders ETF a Buy, Sell or Hold?

  • The current JPMorgan US Tech Leaders ETF [JTEK] share price is $92.66. The Score for JTEK is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • JTEK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
67
Structure Therapeutics, Inc. (GPCR) is a Buy

Is Structure Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Structure Therapeutics, Inc. [GPCR] share price is $69.98. The Score for GPCR is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

JTEK Stock Price Chart

What is JPMorgan US Tech Leaders ETF's stock price today?

  • The JPMorgan US Tech Leaders ETF share price today is $92.66
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JTEK is experiencing buying pressure, which is a positive indicator for future bullish movement.

GPCR Stock Price Chart

What is Structure Therapeutics, Inc.'s stock price today?

  • The Structure Therapeutics, Inc. share price today is $69.98
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing slight buying pressure.

JTEK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.05 Buy
Relative Strength Index (14 RSI): 56.13 Buy
Chaikin Money Flow: 77985 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (87.76 - 93.8) Buy
Bollinger Bands (100): (85.34 - 93.36) Buy

GPCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.48 Buy
Relative Strength Index (14 RSI): 86.01 Buy
Chaikin Money Flow: 124529 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.63 - 42.89) Buy
Bollinger Bands (100): (18.11 - 33.75) Buy

JTEK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 91.44 Buy
20-day SMA: 89.97 Buy
50-day SMA: 92.11 Buy
200-day SMA: 81.89 Buy
8-day EMA: 91.33 Buy
20-day EMA: 90.86 Buy
50-day EMA: 88.77 Buy
200-day EMA: 54.31 Buy

GPCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.22 Buy
20-day SMA: 36.44 Buy
50-day SMA: 32.1 Buy
200-day SMA: 23.71 Buy
8-day EMA: 41.78 Buy
20-day EMA: 37.11 Buy
50-day EMA: 32.59 Buy
200-day EMA: 27.3 Buy

JPMorgan US Tech Leaders ETF Earnings Growth & JTEK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.49 per share, and a decrease next year of $0.15 per share.

JPMorgan US Tech Leaders ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Structure Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):